|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1958)) |
IUPAC Name ![]() |
| 2-BROMO-2-CHLORO-1,1,1-TRIFLUOROETHANE |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 697 | halothane |
Synonyms ![]() |
| Fluothane® |
Database Links ![]() |
|
| BindingDB Ligand | 50112212 |
| CAS Registry No. | 151-67-7 |
| ChEBI | CHEBI:5615 |
| ChEMBL Ligand | CHEMBL931 |
| DrugBank Ligand | DB01159 |
| PharmGKB Drug | PA449845 |
| PubChem CID | 3562 |
| Search Google for chemical match using the InChIKey | BCQZXOMGPXTTIC-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | BCQZXOMGPXTTIC |
| Search PubMed clinical trials | halothane |
| Search PubMed titles | halothane |
| Search PubMed titles/abstracts | halothane |
| Wikipedia | Halothane |
| Comments |
| Halothane is a volatile anaesthetic which causes rapid anaesthesia, but requires use of additional nitrous oxide and/or neuromuscular blocking agents to be fully effective. |